Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: The Cardiovascular Risk in Black South Africans (CRIBSA) study

European Journal of Preventive Cardiology

Volumn 21, Issue 12, 2014, Pages 1549-1556

  Peer, Nasheeta ^a   Steyn, Krisela ^b   Lombard, Carl ^a   Gaziano, Thomas ^c   Levitt, Naomi ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Black; cholesterol; epidemiology; high density lipoprotein cholesterol; lipid management; lipids; low density lipoprotein cholesterol; South Africa; triglycerides; urban

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROGENESIS; BLACK PERSON; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET; DYSLIPIDEMIA; FAT INTAKE; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; PREVALENCE; SCREENING; SOUTH AFRICA; URBAN POPULATION; ATHEROSCLEROSIS; BLOOD; CROSS-SECTIONAL STUDY; DYSLIPIDEMIAS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH; HEALTH DISPARITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; TRIGLYCERIDES; URBAN HEALTH;

EID: 84911913931     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313497865     Document Type: Article

References (39)

1. Norman R, Bradshaw D, Steyn K, et al. Estimating the burden of disease attributable to high cholesterol in South Africa in 2000. S Afr Med J. 2007 ; 97: 708-715
2. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 ; 364: 937-952
3. Steyn K, Damasceno A The World Bank report: disease and mortality in sub-Saharan Africa. 2 nd ed. Washington, DC: The World Bank, 2006, pp. 247-265. Jamison D Feachem R Makgoba M, ed. Washington, DC: The World Bank ; 2006: 247-265.
4. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999 ; 100: 1134-1146
5. Steyn K, Jooste PL, Bourne L, et al. Risk factors for coronary heart disease in the black population of the Cape Peninsula. The BRISK study. S Afr Med J. 1991 ; 79: 480-485
6. Peer N, Steyn K, Lombard C, et al. Rising diabetes prevalence among urban-dwelling black South Africans. PloS One. 2012 ; 7: e43336 - e43336
7. Global Physical Activity Questionnaire and analysis guide 2002. Geneva: WHO ; 2002 :
8. Bonita R, deCourten M, Dwyer T, et al. Surveillance of risk factors for non-communicable disease: the WHO STEP-wise approach (2002). Available at: http://www.who.int/chp/steps/STEPS-Instrument-v2.1.pdf.
9. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984 ; 252: 1905-1907
10. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med. 2006 ; 23: 469-480
11. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: WHO ; 1999 :
12. Diagnosis, management and prevention of the common dyslipidaemias in South Africa - clinical guideline, 2000. S Afr Med J. 2000 ; 90: 164-174, 176-178
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 ; 18: 499-502
14. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Geneva: WHO ; 2000 :
15. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data - or tears: an application to educational enrollments in states of India. Demography. 2001 ; 38: 115-132
16. Oelofse A, Jooste PL, Steyn K, et al. The lipid and lipoprotein profile of the urban black South Africa population of the Cape Peninsula - the BRISK study. S Afr Med J. 1996 ; 86: 162-166
17. Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans. Public Health Nutr. 2002 ; 5: 239-243
18. Maritz F Chronic diseases of lifestyle in South Africa: 1995-2005, technical report. Steyn K Fourie J Temple N, ed. Cape Town: South African Medical Research Council ; 2006: 97-108.
19. Raal FJ. Questioning the importance of LDL cholesterol: don't throw the baby out with the bathwater!. Cardiovasc J Afr. 2008 ; 19: 63-64
20. Ramjeeth A, Butkow N, Raal FJ, et al. The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not at Goal study (SA-NAG). Cardiovasc J Afr. 2008 ; 19: 88-94
21. Sumner AE, Zhou J, Doumatey A, et al. Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West africans and African Americans with metabolic syndrome: implications for cardiovascular disease prevention. CVD Prev Control. 2010 ; 5: 75-80
22. Hill AG, Darko R, Seffah J, et al. Health of urban Ghanaian women as identified by the Women's Health Study of Accra. Int J Gynaecol Obstet. 2007 ; 99: 150-156
23. Muhihi A, Njelekela M, Mpembeni R, et al. Physical activity and cardiovascular disease risk factors among young and middle-aged men in urban Mwanza, Tanzania. Pan Afr Med J. 2012 ; 11: 11-11
24. Chirovsky DR, Fedirko V, Cui Y, et al. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009 ; 16: 404-423
25. Hu G, Cui Y, Jousilahti P, et al. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease. Eur J Prev Cardiol. 2013 ; 20: 89-97
26. Christian JB, Bourgeois NE, Lowe KA. Prevalence, clinical characteristics and treatment patterns of low high-density lipoprotein cholesterol in the US population: National Health and Nutrition Examination Survey 2005-2008. J Cardiovasc Med (Hagerstown). 2011 ; 12: 714-722
27. Guerra R, Wang J, Grundy SM, et al. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA. 1997 ; 94: 4532-4537
28. Bimenya GS, Okot JK, Nangosa H, et al. Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda. Afr Health Sci. 2006 ; 6: 139-144
29. Haslam DW, James WP. Obesity. Lancet. 2005 ; 366: 1197-1209
30. Vorster HH, Venter CS, Wissing MP, et al. The nutrition and health transition in the North West Province of South Africa: a review of the THUSA (Transition and Health during Urbanisation of South Africans) study. Public Health Nutr. 2005 ; 8: 480-490
31. Johansson I, Nilsson LM, Stegmayr B, et al. Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden. Nutr J. 2012 ; 11: 40-40
32. Huxley R, Lewington S, Clarke R. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med. 2002 ; 2: 315-323
33. Ahmed HM, Blaha MJ, Nasir K, et al. Effects of physical activity on cardiovascular disease. Am J Cardiol. 2012 ; 109: 288-295
34. Smith SC, Jackson R, Pearson TA, et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation. 2004 ; 109: 3112-3121
35. Bertolotti M, Maurantonio M, Gabbi C, et al. Review article: hyperlipidaemia and cardiovascular risk. Aliment Pharmacol Ther. 2005 ; 22 (Suppl 2). 28-30
36. Klug E. South African dyslipidaemia guideline consensus statement. S Afr Med J. 2012 ; 102: 178-187
37. Steyn K, Fourie JM, Shepherd J. Detection and measurement of hypercholesterolaemia in South Africans attending general practitioners in private practice - the cholesterol monitor. S Afr Med J. 1998 ; 88: 1569-1574
38. Raal F, Schamroth C, Blom D, et al. CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia. Cardiovasc J Afr. 2011 ; 22: 234-240
39. Dennison CR, Peer N, Lombard CJ, et al. Cardiovascular risk and comorbid conditions among Black South Africans with hypertension in public and private primary care settings: the HiHi study. Ethn Dis. 2007 ; 17: 477-483